Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,573,400.00 in Stock

Key Points

• Director Gary Guthart sold 10,000 shares for about $4.57 million at an average price of $457.34 under a pre-arranged Rule 10b5-1 plan; he retained roughly 1.19 million shares.
• Intuitive Surgical beat quarterly estimates, reporting $3.00 per share in earnings and $3.05 billion in revenue; revenue rose 21.7% year over year.
• Shares fell 3.4% in Thursday trading. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $493.54.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Gary Guthart sold 10,000 shares of the firm's stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the transaction, the director directly owned 1,194,530 shares in the company, valued at approximately $546,306,350.20. The trade was a 0.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Trading Down 3.4%

Shares of Intuitive Surgical stock traded down $16.25 during trading on Thursday, reaching $465.86. The company's stock had a trading volume of 2,805,688 shares, compared to its average volume of 2,446,590. The company has a 50-day moving average price of $406.25 and a two-hundred day moving average price of $432.60. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm has a market cap of $161.48 billion, a PE ratio of 56.53, a P/E/G ratio of 3.04 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts' expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical's quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.40 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a research report on Tuesday, July 28th. Robert W. Baird boosted their price target on Intuitive Surgical from $513.00 to $550.00 and gave the stock an "outperform" rating in a report on Wednesday, October 21st. HSBC downgraded Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective on the stock. in a research report on Thursday, July 30th. BMO Capital Markets reiterated an "outperform" rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Finally, Citigroup dropped their price objective on Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating for the company in a research report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $493.54.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Main Street Group LTD bought a new position in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $27,000. John Boyer Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter valued at $27,000. Compass Wealth Management LLC acquired a new stake in Intuitive Surgical during the 3rd quarter valued at $29,000. Finally, Evergreen Advisors LLC bought a new position in Intuitive Surgical in the 1st quarter valued at $35,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.